sentibio.com (SNTI): Net earnings per share growth forecast for next year

Senti Biosciences, Inc. (SNTI) relies on a team of leading geneticists developing AI circuits to combat cancer. The projected earnings per share (EPS) for year n+1 visualizes this potential, where 0.00 represents the latest level value. Growth is supported by biochip patents attracting pharma behemoths, while a digital database of genetic codes ensures scalability and superprofits from global licenses.

Senti Biosciences, Inc. (SNTI): Net earnings per share growth forecast for next year from 04/28/2023 to 11/14/2026

Summary analytical data breakdowns for Senti Biosciences (SNTI)

- share price and consensus valuation forecast:

Stock Price Senti Bio|SNTI - Average Forecast Price

- stock exchange capitalization data:

Market Value Senti Biosciences|SNTI - Total Company Value

- company book value details:

Net Assets per Single Share Senti Biosciences|SNTI - Company Book Value|Market Cap to Net Assets Ratio sentibio.com|SNTI - Aggregate Asset Value

- debt and solvency information:

- net income and valuation ratios data:

SNTI - Final Profit|Future Profit Senti Biosciences, Inc.|SNTI - Market Price to Net Income Ratio|Forward P/E Multiple Senti Bio|SNTI - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Senti Biosciences|SNTI - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Senti Biosciences|SNTI - Earnings per share for the trailing year|Quarterly EPS earnings growth sentibio.com|SNTI - Earnings growth in current year|Net earnings per share growth forecast for next year Senti Biosciences, Inc.

- company sales and revenue statistics:

SNTI - Company Annual Revenue|Company Future Sales Volume Senti Bio|SNTI - Price to Sales|Price-to-Projected Revenue Ratio Senti Biosciences

Fundamental company analysis:SNTI, Senti Biosciences, Inc.

This indicator aggregates expert estimates of profit dynamics for the coming year, measuring the market consensus regarding net income growth rates. The metric's values react sharply to operational updates, reflecting a revision of the asset's fundamental value. The EPS forecast trend for Senti Biosciences, Inc. (SNTI) on GURU.Markets demonstrates how the diversification of Senti Biosciences, Inc. (SNTI) gene programs and partnerships with pharma behemoths minimize risks, stabilizing investor expectations.

Competing companies